SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-15-001006
Filing Date
2015-02-06
Accepted
2015-02-06 10:20:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 d6344271_13-g.htm SC 13G 117845
  Complete submission text file 0000919574-15-001006.txt   119595
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Subject) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81444 | Film No.: 15582516
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G